The effect of respiratory manoeuvres and pharmacological agents on the pharmacokinetics of nedocromil sodium after inhalation
- PMID: 1315564
- PMCID: PMC1381334
- DOI: 10.1111/j.1365-2125.1992.tb04063.x
The effect of respiratory manoeuvres and pharmacological agents on the pharmacokinetics of nedocromil sodium after inhalation
Abstract
1. Eight healthy subjects inhaled nedocromil sodium from a metered-dose inhaler using a standardised inspiratory technique. Blood samples were taken for up to 270 min after inhalation for radioimmunoassay of plasma nedocromil sodium concentrations. 2. To investigate the possibility that respiratory manoeuvres can alter the absorption of the drug from the lungs, on the first (control) study day at 70 min after dosing, subjects performed nine forced expiratory manoeuvres over a 3 min period. At 110 min after dosing, subjects took a slow, full inspiration with a 30 s breath-hold, and at 150 min after dosing the subjects performed one single forced expiration. 3. On the second study day, subjects inhaled methoxamine, 0.15 mg kg-1 of a 20 mg ml-1 solution at 60 min after dosing, and the study continued as above. On the third day, subjects repeated the sequence of respiratory manoeuvres, after having taken phenoxymethyl penicillin and probenecid by mouth for 48 h. 4. Both multiple forced expirations and the deep inspiration with breath-hold produced significant increases in the absorption of nedocromil sodium. Inhaled methoxamine did not alter airway calibre or the response to the respiratory manoeuvres. Probenecid, but not penicillin, was detected in the subjects' plasma, and had the effect of increasing the rise in plasma nedocromil sodium concentrations after the multiple forced expirations when compared with the control day. 5. These data suggest that disruption of epithelial tight junctions induced by the respiratory manoeuvres leads to enhanced paracellular transport of nedocromil sodium into the draining circulation of the airways and alveoli.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma.Drugs. 1993 May;45(5):693-715. doi: 10.2165/00003495-199345050-00007. Drugs. 1993. PMID: 7686465 Review.
-
The protective efficacy of inhaled, oral and intravenous nedocromil sodium against adenosine-5'-monophosphate-induced bronchoconstriction in asthmatic volunteers.Pulm Pharmacol. 1990;3(4):190-7. doi: 10.1016/0952-0600(90)90016-c. Pulm Pharmacol. 1990. PMID: 1966907
-
The effect of physiological manoeuvres on the absorption of inhaled nedocromil sodium.Br J Clin Pharmacol. 1994 Mar;37(3):305-8. doi: 10.1111/j.1365-2125.1994.tb04281.x. Br J Clin Pharmacol. 1994. PMID: 8198943 Free PMC article. Clinical Trial.
-
Nedocromil sodium inhibits the airway response to hyperosmolar challenge in patients with asthma.Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1149-55. doi: 10.1164/ajrccm/146.5_Pt_1.1149. Am Rev Respir Dis. 1992. PMID: 1359818 Clinical Trial.
-
The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma.Eur Respir J. 1993 Jan;6(1):35-41. Eur Respir J. 1993. PMID: 8381089 Review.
Cited by
-
Antihistamines in the treatment of asthma.Clin Rev Allergy. 1994 Spring;12(1):65-78. doi: 10.1007/BF02815510. Clin Rev Allergy. 1994. PMID: 7915192 Review. No abstract available.
-
Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma.Drugs. 1993 May;45(5):693-715. doi: 10.2165/00003495-199345050-00007. Drugs. 1993. PMID: 7686465 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources